Kodiak Sciences (KOD) Operating Leases (2019 - 2026)
Kodiak Sciences' (KOD) quarterly Operating Leases came in at $44.3 million in Q1 2026, down 21.8% YoY from $56.7 million in Q1 2025, and down 5.91% on a QoQ basis from $47.1 million in Q4 2025.
Analysis
Kodiak Sciences (KOD) Operating Leases (2019 - 2026) Analysis & Trends
Kodiak Sciences (KOD) has 8 years of Operating Leases data on file, last reported at $44.3 million in Q1 2026.
- Quarterly Operating Leases fell 21.8% year-over-year to $44.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $44.3 million (down 21.8% YoY) and the FY2025 annual result came in at $47.1 million, down 21.1% from the prior year.
- Operating Leases fell to $44.3 million in Q1 2026, from $47.1 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $81.0 million in Q2 2022 to a low of $6.8 million in Q2 2023.
- A 5-year average of $62.1 million and a median of $65.9 million in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases plunged 91.6% — and 2024, when it jumped 868.66%.
- Tracing KOD's Operating Leases over 5 years: stood at $77.8 million in 2022, then dropped by 7.64% to $71.9 million in 2023, then fell by 16.9% to $59.7 million in 2024, then dropped by 21.1% to $47.1 million in 2025, then dropped by 5.91% to $44.3 million in 2026.
- The last three Operating Leases figures came in at $44.3 million (Q1 2026), $47.1 million (Q4 2025), and $50.4 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Kodiak Sciences | 2.21 Bn | 2.21 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.95 Mn |
| Mar 31, 2026 | 44.33 Mn |
| Dec 31, 2025 | 47.12 Mn |
| Sep 30, 2025 | 50.45 Mn |
| Jun 30, 2025 | 53.92 Mn |
| Mar 31, 2025 | 56.69 Mn |
| Dec 31, 2024 | 59.72 Mn |
| Sep 30, 2024 | 63.24 Mn |
| Jun 30, 2024 | 65.87 Mn |
| Mar 31, 2024 | 68.72 Mn |
| Dec 31, 2023 | 71.86 Mn |
| Sep 30, 2023 | 74.46 Mn |
| Jun 30, 2023 | 76.94 Mn |
| Mar 31, 2023 | 78.81 Mn |
| Dec 31, 2022 | 77.81 Mn |
| Sep 30, 2022 | 78.70 Mn |
| Jun 30, 2022 | 80.99 Mn |
| Mar 31, 2022 | 76.42 Mn |
| Dec 31, 2021 | 76.06 Mn |
| Sep 30, 2021 | 77.34 Mn |